RCEL AVITA Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RCEL

Price (delayed)

$10.95

Market cap

$338.65M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.43

Enterprise value

$377.99M

?
Relative Growth: Rel. Growth: 57
Relative Strength: Rel. Strength: 99
Relative Valuation: Rel. Valuation: 13
Relative Profitability: Rel. Profitability: 27

AVITA Medical, Inc. is a regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, chronic wounds, and aesthetics indications. AVITA Medical Inc. patented and ...

Highlights
The company's EPS rose by 27% YoY and by 8% QoQ
The net income has grown by 16% YoY and by 5% from the previous quarter
The gross profit has grown by 4.8% since the previous quarter but it has declined by 2.3% year-on-year
AVITA Medical's equity has shrunk by 116% YoY and by 20% QoQ
RCEL's quick ratio is down by 28% year-on-year and by 14% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.avitamedical.com
Peers: NVAX NVCR NBIX

Key stats

What are the main financial stats of RCEL

RCEL stock price

How has the AVITA Medical stock price performed over time
Intraday
-4.7%
1 week
4.78%
1 month
8.85%
1 year
100.92%
YTD
217.39%
QTD
165.13%

Financial performance

How have AVITA Medical's revenue and profit performed over time
Revenue
$75.63M
Gross profit
$61.68M
Operating income
-$35.22M
Net income
-$43.08M
Gross margin
81.6%
Net margin
-57%
RCEL's operating margin is up by 25% YoY and by 15% from the previous quarter
The operating income has grown by 25% YoY and by 11% from the previous quarter
RCEL's net margin is up by 17% year-on-year and by 9% since the previous quarter
The net income has grown by 16% YoY and by 5% from the previous quarter

Price vs fundamentals

How does RCEL's price correlate with its fundamentals

Growth

What is AVITA Medical's growth rate over time

Valuation

What is AVITA Medical stock price valuation
P/E
N/A
P/B
N/A
P/S
4.45
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5
The company's EPS rose by 27% YoY and by 8% QoQ
AVITA Medical's equity has shrunk by 116% YoY and by 20% QoQ
The P/S is 192% above the last 4 quarters average of 1.6 but 12% below the 5-year quarterly average of 5.3
The revenue has grown by 4.5% from the previous quarter

Efficiency

How efficient is AVITA Medical business performance
The ROIC has plunged by 167% YoY and by 4.7% from the previous quarter
The company's return on sales rose by 20% YoY and by 10% QoQ
The return on assets has declined by 10% year-on-year

Dividends

What is RCEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RCEL.

Financial health

How did AVITA Medical financials performed over time
The total assets is 37% smaller than the total liabilities
AVITA Medical's current ratio has decreased by 29% YoY and by 13% QoQ
RCEL's quick ratio is down by 28% year-on-year and by 14% since the previous quarter
AVITA Medical's equity has shrunk by 116% YoY and by 20% QoQ
RCEL's debt to equity is up by 50% year-on-year and by 16% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.